Nadia Purnama Dewi, Sandeep Poddar, Dessy Abdullah, Ade Teti Vani
Nadia Purnama Dewi1,3, Sandeep Poddar2*, Dessy Abdullah1,3, Ade Teti Vani3
1Research Scholar, Lincoln University College, Wisma Lincoln, 12-18, Jalan SS 6/12, 47301 Petaling Jaya, Selangor D. E, Malaysia.
2Deputy Vice Chancellor (Research & Innovations), Lincoln University College, Wisma Lincoln, 12-18, Jalan SS 6/12, 47301 Petaling Jaya, Selangor D. E, Malaysia.
3Lecturer, Medical Faculty, University of Baiturrahmah, Jalan Raya By Pass, Aie Pacah, Koto Tangah, Aie Pacah, Kec. Koto Tangah, Kota Padang, Sumatera Barat 25586, Indonesia.
Volume - 16,
Issue - 10,
Year - 2023
Pediococcus acidilactici is one of the lactic acid bacteria that acts as a probiotic isolated from buffalo milk fermentation (Dadiah). Dadiah is a functional food that is rich in lactic acid bacteria and acts as a probiotic. Probiotics have many health benefits for humans and animals, one of which is as a Tumor Necrosis Factor (TNF) expression inhibitor which is able to suppress the physiological response to TNF which is part of the inflammatory response where TNF itself is involved in autoimmune and immune disorders. So with the use of TNF inhibitors from secondary metabolites Pediococcus acidilactici can prevent and treat TNF. This study aims to determine the secondary metabolites of Pediococcus acidilactici to TNF inhibitor and immunomodulator expression by looking at the canonical and isomeric SMILE (simplified molecular-input line-entry system) structures in the Pub Chem database. After conducting bioinformatics analysis to determine the secondary metabolites of Pediococcus acidilactici, the value of TNF inhibitor expression was 0.63 and as an immunomodulator 0.42 meaning that Pediococcus acidilactici isolated from Dadiah from Bukittinggi was able to act as TNF inhibitor and immunomodulator expression.
Cite this article:
Nadia Purnama Dewi, Sandeep Poddar, Dessy Abdullah, Ade Teti Vani. Potential of Pediococcus acidilactici DS1 from Dadiah Bukitinggi as a Tumor Necrosis Factor (TNF) Expression Inhibitor in Bioinformatics. Research Journal of Pharmacy and Technology 2023; 16(10):4737-0. doi: 10.52711/0974-360X.2023.00769
Nadia Purnama Dewi, Sandeep Poddar, Dessy Abdullah, Ade Teti Vani. Potential of Pediococcus acidilactici DS1 from Dadiah Bukitinggi as a Tumor Necrosis Factor (TNF) Expression Inhibitor in Bioinformatics. Research Journal of Pharmacy and Technology 2023; 16(10):4737-0. doi: 10.52711/0974-360X.2023.00769 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-10-39
1. Mojgani N, Shahali Y, Dadar M. Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine development. Beneficial microbes. 2020;11(3):213-26.https://doi.org/10.3920/BM2019.0121
2. Devi SM, Kurrey NK, Halami PM. In vitro anti-inflammatory activity among probiotic Lactobacillus species isolated from fermented foods. Journal of Functional Foods. 2018;47:19-27. https://doi.org/10.1016/j.jff.2018.05.036
3. Nagpal R, Kumar A, Kumar M, Behare PV, Jain S, Yadav H. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS microbiology letters. 2012; 334(1): 1-5. https://doi.org/10.1111/j.1574-6968.2012.02593.x
4. Yadav M, Shukla P. Efficient engineered probiotics using synthetic biology approaches: A review. Biotechnology and applied biochemistry. 2020;67(1):22-9. https://doi.org/10.1002/bab.1822
5. Verna EC, Lucak S. Use of probiotics in gastrointestinal disorders: what to recommend?. Therapeutic advances in gastroenterology. 2010;3(5):307-19. https://doi.org/10.1177/1756283X10373814
6. Yadav M, Shukla P. Recent systems biology approaches for probiotics use in health aspects: a review. 3 Biotech. 2019; 9(12): 1-0. https://doi.org/10.1007/s13205-019-1980-5
7. Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr 10: S49–S66.
8. Hossain MK, Nahar K, Shokryazdan P, Abdullah N, Hamid K, Jahromi MF. Probiotic potential of lactic acid bacteria isolated from cheese, yogurt and poultry faeces. Research Journal of Pharmacy and Technology. 2017;10(9):2991-8. https://doi.org/10.5958/0974-360X.2017.00530.3
9. Swathi KV. Probiotics-A human friendly bacteria. Research Journal of Pharmacy and Technology. 2016;9(8):1260-2. https://doi.org/10.5958/0974-360X.2016.00239.0
10. Dey A, Ragavan ML, Mandal SK, Das N. Isolation, identification and In vitro characterisation of probiotic yeast strains. Res. J. Pharm. Technol. 2017;10(3):726-32. https://doi.org/10.5958/0974-360X.2017.00136.6
11. Bhagat BV, Jagtap AR, Hapse SA, Pagar HJ, Wagh AS, Kale NR. Formulation and Evaluation of Probiotic Gel Containing Anti-inflammatory agent for Treatment of IBDS. Research Journal of Pharmacy and Technology. 2012;5(3):387.
12. Nayak BK, Nanda A, Anbarasi P. Assessing the adhesion properties of isolated probiotic Bacillus subtilis to human colonic epithelial cells. Research Journal of Pharmacy and Technology. 2016;9(4):394-6. https://doi/10.5958/0974-360X.2016.00071.8
13. Indira M, Venkateswarulu TC, Chakravarthy K, Reddy AR, Prabhakar KV. Isolation and characterization of bacteriocin producing lactic acid bacteria from diary effluent. Res J Pharm Technol. 2015 Nov 28;8:1-6.
14. Lokhande S, More S, Raje V. A systematic study of probiotics-an update review. Asian Journal of Pharmacy and Technology. 2018; 8(3).
15. Filimonov DA, Lagunin AA, Gloriozova TA, Rudik AV, Druzhilovskii DS, Pogodin PV, Poroikov VV. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chemistry of Heterocyclic Compounds. 2014; 50(3):444-57. https://doi.org/10.1007/s10593-014-1496-1
16. Karamese M, Aydin H, Sengul E, Gelen V, Sevim C, Ustek D, Karakus E. The immunostimulatory effect of lactic acid bacteria in a rat model. Iranian Journal of Immunology. 2016;13(3):220-8.
17. Azad AK, Sarker M, Wan D. immunomodulatory effect of probiotics on cytokine profile. Bio Med Res Int 2018; 2:1-10.https://doi.org/10.1155/2018/8063647
18. Scharl M. Pathophysiological role of TNF in inflammatory bowel disease: TNF and its effect on innate immune defense. InAnti-tumor necrosis factor therapy in inflammatory bowel disease 2015 (Vol. 34, pp. 49-55). Karger Publishers. https://doi.org/10.1159/000381409
19. Akash MS, Rehman K, Liaqat A. Tumor necrosis factor‐alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. Journal of Cellular Biochemistry. 2018; 119(1):105-10. https://doi.org/10.1002/jcb.26174
20. Pini A, Obara I, Battell E, Chazot PL, Rosa AC. Histamine in diabetes: is it time to reconsider?. Pharmacological Research. 2016; 111: 316-24. https://doi.org/10.1016/j.phrs.2016.06.021
21. Azizian MS N. Involvement of the receptor for advanced glycation end products (rage) in progression of pancreatic cancer.
22. Albensi BC. What is nuclear factor kappa B (NF-κB) doing in and to the mitochondrion?. Frontiers in Cell and Developmental Biology. 2019;7:154. https://doi.org/10.3389/fcell.2019.00154